MAI Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
MAI Capital Management's FBT Position: Q3 2026 in Review
MAI Capital Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.8% in Q3 2026, selling an estimated $116K and leaving 7,179 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #706.
MAI Capital Management first reported a position in FBT in Q4 2021 and has held it in 20 quarters since. 296 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- MAI Capital Management held 7,179 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.95M as of Q3 2026.
- MAI Capital Management sold 446 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $116K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of MAI Capital Management's portfolio in Q3 2026, its #706 holding.
- MAI Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 20 quarters since.
- 296 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.